Home

Senores Pharmaceuticals Ltd PE Ratio

Image

Senores Pharmaceuticals Ltd

NSE: SENORES

PE

83.8

Last updated on: Jan 03, 2025

Key Highlights

  • The P/E Ratio of Senores Pharmaceuticals Ltd is 83.8 as of 03 Jan 25 .
  • The P/E Ratio of Senores Pharmaceuticals Ltd changed from 0 on March 2022 to 0 on March 2024 . This represents a CAGR of 0.0% over 3 years.
  • The Latest Trading Price of Senores Pharmaceuticals Ltd is ₹ 573 as of 03 Jan 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Senores Pharmaceuticals Ltd

No data available

Company Fundamentals for Senores Pharmaceuticals Ltd

Image

Senores Pharmaceuticals Ltd

NSE: SENORES

Share Price

₹ 573

0.20 (0.03%)

stock direction

Last updated on: Jan 03, 2025

Market Price of Senores Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Senores Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
03 Jan 2025573
02 Jan 2025572.8
01 Jan 2025571.2
31 Dec 2024568.9
30 Dec 2024557.8

BlinkX Score for Senores Pharmaceuticals Ltd

Asset Value vs Market Value of Senores Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PE Ratio of Senores Pharmaceuticals Ltd Explained

2638

Market cap

0

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Senores Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Senores Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Senores Pharmaceuticals Ltd

No data available

* All values are in %

About Senores Pharmaceuticals Ltd

  • Senores Pharmaceuticals Limited was originally incorporated as 'Senores Pharmaceuticals Private Limited' through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
  • Thereafter, the name of the Company was changed to 'Senores Pharmaceuticals Limited' upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms.
  • The Regulated Markets business is focused on Regulated Markets of US and Canada.
  • The Company has adopted a strategy of identifying, developing and commercializing specialty and complex niche products in the mid-market range and received approvals for 19 ANDAs.

Senores Pharmaceuticals Ltd News Hub

Senores Pharmaceuticals IPO subscribed 93.41 times

The initial public offer (IPO) of Senores Pharmaceuticals received bids for 79,72,30,918 shares as a

Read more

2024-12-24 00:00:00

Senores Pharmaceuticals IPO ends with 93.69x subscription

The initial public offer (IPO) of Senores Pharmaceuticals received bids for 79,95,96,646 shares as a

Read more

2024-12-26 00:00:00

Senores Pharmaceuticals IPO subscribed 1.78 times

The initial public offer (IPO) of Senores Pharmaceuticals received bids for 1,51,51,550 shares as ag

Read more

2024-12-20 00:00:00

Senores Pharmaceuticals makes strong debut

The scrip was listed at Rs 593.70, exhibiting a premium of 51.84% to the issue price. So far, the st

Read more

2024-12-30 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions